Patents by Inventor FADOUA MONTASSAR

FADOUA MONTASSAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lebecetin, a C-type lectin, as neovascularization inhibitor
    Patent number: 11191807
    Abstract: The present invention relates to lebecetin, a functional variant or fragment thereof, for use as neovascularization inhibitor, in particular in the treatment of neovascular diseases such as ocular diseases, cancers or inflammatory disorders with a neovascular component.
    Type: Grant
    Filed: December 12, 2017
    Date of Patent: December 7, 2021
    Assignees: SARBONNE INIVERSIÉ, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MEDICALE), INSTITUT PASTEUR DE TUNIS
    Inventors: Xavier Guillonneau, Fadoua Montassar, Naziha Marrakchi, Erij Messadi, Florian Sennlaub, José-Alain Sahel
  • LEBECETIN, A C-TYPE LECTIN, AS NEOVASCULARIZATION INHIBITOR
    Publication number: 20190298797
    Abstract: The present invention relates to lebecetin, a functional variant or fragment thereof, for use as neovascularization inhibitor, in particular in the treatment of neovascular diseases such as ocular diseases, cancers or inflammatory disorders with a neovascular component.
    Type: Application
    Filed: December 12, 2017
    Publication date: October 3, 2019
    Inventors: XAVIER GUILLONNEAU, FADOUA MONTASSAR, NAZIHA MARRAKCHI, ERIJ MESSADI, FLORIAN SENNLAUB, JOSÉ-ALAIN SAHEL